![Detection of mutations in CML patients resistant to tyrosine kinase inhibitor: imatinib mesylate therapy | SpringerLink Detection of mutations in CML patients resistant to tyrosine kinase inhibitor: imatinib mesylate therapy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12032-021-01571-1/MediaObjects/12032_2021_1571_Fig2_HTML.png)
Detection of mutations in CML patients resistant to tyrosine kinase inhibitor: imatinib mesylate therapy | SpringerLink
Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells | PLOS ONE
![Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. | Australian Medical Student Journal Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. | Australian Medical Student Journal](http://www.amsj.org/wp-content/uploads/2017/08/Picture1.png)
Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. | Australian Medical Student Journal
![Targeting SOS1 overcomes imatinib resistance with BCR-ABL independence through uptake transporter SLC22A4 in CML: Molecular Therapy - Oncolytics Targeting SOS1 overcomes imatinib resistance with BCR-ABL independence through uptake transporter SLC22A4 in CML: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/3c87005e-075e-4d6a-aafd-7bb230d6b18b/fx1_lrg.jpg)
Targeting SOS1 overcomes imatinib resistance with BCR-ABL independence through uptake transporter SLC22A4 in CML: Molecular Therapy - Oncolytics
![Cancers | Free Full-Text | Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance Cancers | Free Full-Text | Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance](https://www.mdpi.com/cancers/cancers-13-04820/article_deploy/html/images/cancers-13-04820-g001.png)
Cancers | Free Full-Text | Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance
![Second generation inhibitors of BCR-ABL for the treatment of imatinib- resistant chronic myeloid leukaemia | Nature Reviews Cancer Second generation inhibitors of BCR-ABL for the treatment of imatinib- resistant chronic myeloid leukaemia | Nature Reviews Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrc2126/MediaObjects/41568_2007_Article_BFnrc2126_Fig1_HTML.jpg)
Second generation inhibitors of BCR-ABL for the treatment of imatinib- resistant chronic myeloid leukaemia | Nature Reviews Cancer
![PDF] Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML). | Semantic Scholar PDF] Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/800ff3e36d003a19dad5dd24b03c15a74f708084/14-Figure3-1.png)
PDF] Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML). | Semantic Scholar
![Imatinib Resistance and Progression of CML to Blast Crisis: Somatic Hypermutation AIDing the Way - ScienceDirect Imatinib Resistance and Progression of CML to Blast Crisis: Somatic Hypermutation AIDing the Way - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S153561080900258X-gr1.jpg)
Imatinib Resistance and Progression of CML to Blast Crisis: Somatic Hypermutation AIDing the Way - ScienceDirect
![PDF] Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia | Semantic Scholar PDF] Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0a9b23d5cd08b70bab6df94e2948ce56a8452958/6-Figure1-1.png)
PDF] Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia | Semantic Scholar
Towards a Molecular Understanding of the Link between Imatinib Resistance and Kinase Conformational Dynamics | PLOS Computational Biology
![IJMS | Free Full-Text | Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update IJMS | Free Full-Text | Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update](https://www.mdpi.com/ijms/ijms-20-06141/article_deploy/html/images/ijms-20-06141-g001.png)
IJMS | Free Full-Text | Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update
![Mechanisms of Autoinhibition and STI-571/Imatinib Resistance Revealed by Mutagenesis of BCR-ABL: Cell Mechanisms of Autoinhibition and STI-571/Imatinib Resistance Revealed by Mutagenesis of BCR-ABL: Cell](https://www.cell.com/cms/attachment/73c95d18-05f8-4967-a5ea-28e6cb9c773d/gr1.jpg)
Mechanisms of Autoinhibition and STI-571/Imatinib Resistance Revealed by Mutagenesis of BCR-ABL: Cell
![Mechanisms of CML cells resistance to TKI. BCR-ABL dependent mechanisms... | Download Scientific Diagram Mechanisms of CML cells resistance to TKI. BCR-ABL dependent mechanisms... | Download Scientific Diagram](https://www.researchgate.net/publication/255736827/figure/fig3/AS:1089048835821582@1636660884429/Mechanisms-of-CML-cells-resistance-to-TKI-BCR-ABL-dependent-mechanisms-include-1.jpg)